| Financial Year |
March 31 2023 |
| Monetary Funds |
2,165,594,185.52 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
22,737,246.11 |
| Accounts Receivable |
175,445,855.82 |
| Advances to Suppliers |
45,722,837.32 |
| Other Receivables |
18,142,002.32 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
905,067,879.48 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
16,020,065.43 |
| Total Current Assets |
3,995,789,129.35 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
6,154,334.02 |
| Investment Properties |
164,958,396.50 |
| Fixed Assetes |
5,425,208,313.08 |
| Under-construction Projects |
275,645,900.76 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
388,957,147.60 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
11,144,347.12 |
| Deferred Income Tax Assets |
80,000,309.50 |
| Other Non-Current Assets |
307,030,326.99 |
| Sub-Total of Non-Current Assets |
7,972,088,264.40 |
| Total Assets |
11,967,877,393.75 |
| Short-Term Loans |
66,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
681,636,338.93 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
26,311,032.84 |
| Taxes Payable |
76,323,058.79 |
| Interest Payable |
166,635.17 |
| Dividend Payable |
23,596.96 |
| Other payables |
497,935,652.88 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
1,869,841,571.39 |
| Long-term Loans |
39,690,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
275,950,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
140,300,000.00 |
| Deferred Income Tax Liabilities |
100,355,721.08 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
586,144,036.22 |
| Total Liabilities |
2,455,985,607.61 |
| Paid-In Capital(Or Share Stock) |
8,602,447,902.00 |
| Capital Surplus |
3,703,994,778.07 |
| Surplus Reserve |
252,141,007.86 |
| LESS:Treasury Stock |
26,419,536.00 |
| Undistributed Profits |
-3,987,129,507.84 |
| Minority Stockholder's Interest |
376,923,274.24 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
9,134,968,511.90 |
| Owner's Equity（Stockholder's Equity） |
9,511,891,786.14 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
11,967,877,393.75 |
